Superluminal Medicines, Inc.

Superluminal Medicines is a generative biology and chemistry company revolutionizing the speed and accuracy of how small molecule medicines are created. The company aims to develop candidate-ready compounds with unprecedented speed using a combination of deep biology, computational and medicinal chemistry, machine learning, and proprietary big data infrastructure. Superluminal is expanding its team of talented individuals who seek to build the future of small molecule drug discovery with creativity and innovation.